7/13, 10:10 AM (Source: TeleTrader)
more TeleTrader news

Equillium drug could be used to treat COVID-19

Equillium Inc., a biotechnology company from the United States, stated on Monday it plans to file an investigational new drug application for its psoriasis drug itolizumab after it was proven effective as a treatment for COVID-19.

The decision was made after Biocon Limited, the company's partner from India, proved in a clinical trial that itolizumab reduces mortality in coronavirus patients. Equillium is looking to conduct a global, randomized trial before going through with the application.

"We are working with Biocon to review its full dataset to move swiftly in determining appropriate next steps to accelerate further development of itolizumab to treat moderate to severely ill COVID-19 patients in the US and abroad in the face of this global crisis," the company's CEO Bruce Steel said.

Breaking the News / BU